Statement of Changes in Beneficial Ownership (4)
11 März 2021 - 10:25PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Doherty Catherine T. |
2. Issuer Name and Ticker or Trading Symbol
QUEST DIAGNOSTICS INC
[
DGX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP, Group Exec. Clin. Fran. |
|
(Last)
(First)
(Middle)
500 PLAZA DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
3/9/2021 |
|
(Street)
SECAUCUS, NJ 07094
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Common Stock | 3/9/2021 | | A | | 11299 (1) | A | $115.42 | 82331 | D | |
| Common Stock | 3/9/2021 | | F | | 5066 (2) | D | $115.42 | 77265 | D | |
| Common Stock | | | | | | | | 4098 (3) | I | 401(k)/SDCP |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Explanation of Responses: |
| (1) | Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). |
| (2) | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. |
| (3) | These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Doherty Catherine T.
500 PLAZA DRIVE
SECAUCUS, NJ 07094 |
|
| SVP, Group Exec. Clin. Fran. |
|
Signatures
|
| /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Catherine T. Doherty | | 3/11/2021 |
| **Signature of Reporting Person | Date |
Quest Diagnostics (NYSE:DGX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Quest Diagnostics (NYSE:DGX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
